MedPath

FONDAPARINUX SODIUM INJECTION

FONDAPARINUX SODIUM INJECTION

Approved
DIN Number

02406896

Drug Class

Human

Market Date

Mar 21, 2014

Company
HC

dr reddy's laboratories ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02406896
AIG Number0146781002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AX05 FONDAPARINUX
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:12.04.14
Health Canada Classification

ACTIVE INGREDIENTS (1)

FONDAPARINUX SODIUMActive
Strength: 7.5 MG / 0.6 ML
Monograph: FONDAPARINUX SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.